Vildagliptin improves high glucose‐induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission

The dipeptidyl peptidase 4 inhibitor vildagliptin (VLD), a widely used anti‐diabetic drug, exerts favourable effects on vascular endothelium in diabetes. We determined for the first time the improving effects of VLD on mitochondrial dysfunction in diabetic mice and human umbilical vein endothelial c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cell Mol Med
Autors principals: Liu, Hengdao, Xiang, Hong, Zhao, Shaoli, Sang, Haiqiang, Lv, Fenghua, Chen, Ruifang, Shu, Zhihao, Chen, Alex F., Chen, Shuhua, Lu, Hongwei
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6349192/
https://ncbi.nlm.nih.gov/pubmed/30444033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13975
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars